These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 5467817

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Behavior of hemodynamic values of patients with hypertension during dichlorphenylamino-imidazoline therapy].
    Pozenel H.
    Wien Klin Wochenschr; 1969 Mar 14; 81(11):187-92. PubMed ID: 4935483
    [No Abstract] [Full Text] [Related]

  • 3. [Single dose studies on the effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-hydrochloride on blood pressure and pulse in hypertonic subjects and on its tolerance].
    Knobloch H, Moor H.
    Arzneimittelforschung; 1966 Sep 14; 16(9):1169-74. PubMed ID: 6014737
    [No Abstract] [Full Text] [Related]

  • 4. Clinical observations on a new antihypertensive drug, 2-(2,6-dichlorphenylamine)-2-imidazoline hydrochloride.
    Smet G, Hoobler SW, Sanbar S, Julis S.
    Am Heart J; 1969 Apr 14; 77(4):473-8. PubMed ID: 5773738
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Effect of prolonged treatment with 2-(2,6-dichlorophenylamine)-2-imidazoline HCl on renal hemodynamics in arterial hypertension].
    Ludwig H.
    Arzneimittelforschung; 1968 May 14; 18(5):600-4. PubMed ID: 5755891
    [No Abstract] [Full Text] [Related]

  • 7. [On hypertension therapy with 2-(2,6-dichlorophenylamino-)2-imidazoline hydrochloride (Catapresan)].
    Fritsch H, Bachmann GW, Lenhard J.
    Med Klin; 1969 May 02; 64(18):842-7. PubMed ID: 4389564
    [No Abstract] [Full Text] [Related]

  • 8. [Blood pressure and heart rate of rats after repeated treatment with 2-(2,6-dichlorphenylamino)-2-imidazoline].
    Walland A.
    Arzneimittelforschung; 1968 Jul 02; 18(7):833-6. PubMed ID: 5755830
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of moxonidine in mild to moderate hypertension.
    Jain S, Malhotra P, Kumari S, Varma S.
    J Assoc Physicians India; 2001 Aug 02; 49():829-30. PubMed ID: 11837474
    [Abstract] [Full Text] [Related]

  • 12. [Clinical and experimental study with the new blood pressure depressant 2-(2,6-dichlorphenylamino)-2-imidazole-hydrochloride].
    Grabner G, Michalek P, Pokorny D, Vormittag E.
    Arzneimittelforschung; 1966 Sep 02; 16(9):1174-9. PubMed ID: 6014738
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Moxonidine vs. captopril in minor to intermediate hypertension. Double-blind study of effectiveness and tolerance].
    Lotti G, Gianrossi R.
    Fortschr Med; 1993 Sep 30; 111(27):429-32. PubMed ID: 8225149
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Side effects of contraceptive drugs].
    Schreiner WE.
    Schweiz Med Wochenschr; 1970 May 02; 100(18):778-84. PubMed ID: 5494369
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.